[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"Vascular Investigation Network Spanish Society for Angiology and Vascular Surgery\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":49},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":4,"hasResults":10,"nctId":11,"briefTitle":12,"officialTitle":12,"acronym":4,"eligibilityCriteria":13,"healthyVolunteers":10,"sex":14,"minAge":15,"maxAge":16,"enrollmentInfo":17,"targetDuration":20,"studyType":21,"phases":4,"briefSummary":22,"conditions":23,"keywords":32,"overallStatus":37,"whyStopped":4,"lastUpdateSubmitDate":38,"lastUpdatePostDateStruct":39,"startDateStruct":42,"completionDateStruct":44,"leadSponsor":46,"locationsCount":5},"100463055",false,"NCT05309707","ENDOBARC-S Study: \"Endovascular Branched Stent-grafts for Aortic ARCh Pathologies in Spain\"","Inclusion Criteria:\n\n* Patient is between 18 and 90 years old\n* Patient with aortic arch pathologies (aneurysm, pseudoaneurysm, dissection, penetrating ulcer, intramural hematoma), treated by branched stent-grafts (Nexus stent graft system©, Relay® Branch or Zenith arch branch graft®, with proximal landing at zone 0.\n* Patient must be available for the appropriate follow-up times for the duration of the study\n* Informed consent signed.\n\nExclusion Criteria:\n\n* Patient less than 18 years old or more than 90 years old.\n* Patient has allergies to materials necessary for endovascular repair (e.g. contrast media, anticoagulants or heparin, nitinol, polyester, gold, platinum-iridium)\n* Patient has systemic infection or suspected systemic infection\n* Patient has thrombocytopenia (platelet count \\\u003C 150000\u002Fµl)\n* Patient has untreated hyperthyroidism\n* Patient has a progressive or untreated malignancy.\n* Patient is pregnant or breastfeeding.\n* Patient has a life expectancy of less than 1 year.\n* Not informed consent signed","ALL","18 Years","90 Years",{"count":18,"type":19},100,"ESTIMATED","5 Years","OBSERVATIONAL","The ENDOBARC-S post-market clinical follow-up study is undertaken to evaluate the prevention of death related to aortic arch pathologies when treated by branch stent graft systems (Nexus stent-graft system®, Relay Branch® or Zenith arch branch graft®), with proximal landing at zone 0.\n\nThe secondary objective is to evaluate the safety and clinical performance of the studied devices.",[24,25,26,27,28,29,30,31],"Thoracic Aortic Aneurysm","Thoracic Aortic Dissection","Stent-Graft Endoleak","Stent-Graft Stenosis","Intramural Hematoma","Aortic Diseases","Cardiovascular Diseases","Vascular Diseases",[33,34,35,36],"Aorta","Thoracic aortic aneurysm","Thoracic aorta dissection","Endovascular repair","RECRUITING","2022-03-24",{"date":40,"type":41},"2022-04-04","ACTUAL",{"date":43,"type":41},"2022-01-01",{"date":45,"type":19},"2027-12-31",{"name":47,"class":48},"Vascular Investigation Network Spanish Society for Angiology and Vascular Surgery","NETWORK",""]